[Acute and chronic cerebrovascular diseases. A therapeutic approach].
The effectiveness of a specific treatment for ictus in its acute phase is highly controversial. A series of variables is identified in 1503 cases that would appear to have a particular effect on the reduction of mortality. On these, specific treatment with Buflomedil coincides with a reduction in lethal outcome of 4% over the two-year period out of 380 cases. In their turn chronic postictal and cerebral ischaemia states (a total of 105 cases) respond positively to prolonged treatment with Buflomedil in a percentage varying from 57% in postictal chronic states to 70-73% in chronic cerebral ischemias.
Bossi
E
E
Ospedale Maria Vittoria, Torino.
Bossi
L
L
D001921:Brain / Q000000981:diagnostic imaging; D002545:Brain Ischemia / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D004569:Electroencephalography; D006801:Humans; D011759:Pyrrolidines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D014665:Vasodilator Agents / Q000627:therapeutic use*
D011759:Pyrrolidines; D014665:Vasodilator Agents; C010651:buflomedil
Vasculopatie encefaliche acute e croniche. Approccio terapeutico.